CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 1 filers reported holding CARDIOME PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 45 | -94.2% | 0.00% | – |
| Q3 2015 | $6,000 | -60.0% | 776 | -52.8% | 0.00% | – |
| Q2 2015 | $15,000 | 0.0% | 1,645 | 0.0% | 0.00% | – |
| Q1 2015 | $15,000 | – | 1,645 | +3555.6% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 45 | -99.6% | 0.00% | – |
| Q3 2014 | $107,000 | -61.4% | 12,011 | -65.9% | 0.00% | – |
| Q2 2014 | $277,000 | +20.4% | 35,265 | +21.3% | 0.00% | – |
| Q1 2014 | $230,000 | – | 29,065 | +44615.4% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 65 | -75.5% | 0.00% | – |
| Q3 2013 | $1,000 | – | 265 | +1225.0% | 0.00% | – |
| Q2 2013 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alistair Capital Management, L.L.C. | 917,400 | $5,715,000 | 2.56% |
| Fortress Investment Group LLC | 2,481,596 | $15,460,000 | 0.24% |
| PERKINS CAPITAL MANAGEMENT INC | 14,000 | $87,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,332,260 | $8,386,000 | 0.02% |
| TFS CAPITAL LLC | 26,116 | $163,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 54,815 | $342,000 | 0.01% |
| Renaissance Technologies | 218,913 | $1,364,000 | 0.00% |
| Alberta Investment Management Corp | 19,140 | $128,000 | 0.00% |
| OAK RIDGE INVESTMENTS LLC | 11,055 | $69,000 | 0.00% |
| CLEAR STREET MARKETS LLC | 600 | $4,000 | 0.00% |